US EditionWhat's Going On With NLS Pharmaceutics Stock Friday?
Summary by Cryptocurrency News | Cryptocurrency Prices | Market Cap
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Kadimastem Shareholders Greenlight Merger with NLS
The approval moves NLS and Kadimastem closer to forming a combined Nasdaq-traded biotechnology company. Summary: Kadimastem shareholders have approved the company’s merger with NLS Pharmaceutics, moving the two firms closer to forming a combined Nasdaq-traded company. NLS plans to hold its own shareholder vote in the coming weeks to finalize the merger. Executives from both companies highlighted the potential value creation and opportunities for…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
